Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.
about
Erythropoietin and diabetes mellitusStem cell guidance through the mechanistic target of rapamycinErythropoietin: new directions for the nervous systemTargeting disease through novel pathways of apoptosis and autophagyShedding new light on neurodegenerative diseases through the mammalian target of rapamycinWnt your brain be inflamed? Yes, it Wnt!New Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseOxidative stress induced age dependent meibomian gland dysfunction in Cu, Zn-superoxide dismutase-1 (Sod1) knockout miceDifferential expression of Wnts after spinal cord contusion injury in adult rats.WISP1: Clinical insights for a proliferative and restorative member of the CCN familyPRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotectionMethod parameters' impact on mortality and variability in rat stroke experiments: a meta-analysis.EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Translating cell survival and cell longevity into treatment strategies with SIRT1Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia.Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xLSIRT1: new avenues of discovery for disorders of oxidative stressPrevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy.Regeneration in the nervous system with erythropoietinOxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeWnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia.Obesity and hyperglycemia lead to impaired post-ischemic recovery after permanent ischemia in mice.Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for nWISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1Wnts are expressed in the spinal cord of adult mice and are differentially induced after injury.Targeting erythropoietin for chronic neurodegenerative diseases.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Activation of Wnt/β-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity.Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway.Signaling of reactive oxygen and nitrogen species in Diabetes mellitus.Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function.Expression of Nemo-like kinase after spinal cord injury in rats.Microvesicle-mediated Wnt/β-Catenin Signaling Promotes Interspecies Mammary Stem/Progenitor Cell Growth.Protective effect of autophagy in neural ischemia and hypoxia: Negative regulation of the Wnt/β-catenin pathway.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.FoxO proteins in the nervous system.MicroRNA-140-5p elevates cerebral protection of dexmedetomidine against hypoxic-ischaemic brain damage via the Wnt/β-catenin signalling pathway.
P2860
Q26777878-B9EAB4C7-E081-4EB5-BF17-CA846A1D27EAQ26795544-F052866E-3871-494A-A20B-B24E2B85AC8DQ26828425-720CA664-9074-4068-A98C-8D9E2D6073B4Q26864639-E0C062E8-446C-4013-A42A-F8F0B4A18239Q27015640-45DCB6D7-9ADD-4BA3-B8F5-48E4EAA6DB0CQ27022507-203A5B1B-705D-4643-B20F-ACE5EFA3CAA8Q28080679-9F347177-DAEB-4B39-AAEE-3BC74A559069Q28085715-B4606B4F-AC08-4184-A980-CD13D8250DD6Q33921185-E8EBD09E-B965-4174-A2DC-DAD54D73C764Q34071712-DAA5E11F-1381-4BFD-AE0B-56A4843D9A7BQ34381111-0B8032C1-F81C-4C4E-A6A3-A2A1383D5305Q34429082-F4D782B1-09BC-4375-8E58-54565C503288Q34645508-77781F5C-A657-4D3E-87C1-2F07056AB541Q34887803-F20A2794-C0B3-4CC9-A795-F4C244503AA7Q35157985-BB8D99DB-FE4B-4380-B81B-7AD032D7E0AEQ35660308-944A8388-FA9B-4D5E-9ED1-E326DE5530A7Q35663684-6D0B4BCB-F5C1-40E0-8D1B-F632109B68E8Q35742785-99F07B60-6027-4FDD-87FE-BF8515C09AFAQ35757288-60679A2B-26A6-493A-B4F6-A36B0CF3FEECQ35947388-35D4AA31-3240-4153-AB38-3FA0087318CDQ35965763-4999E960-6121-45FD-A973-DB0748085ADEQ36247651-B731B484-D355-49CA-8D17-FE2EF9524A8BQ36432388-352C5DAB-CC57-41F8-AE18-D028B2305E29Q36465550-1AF727E1-738E-4417-8100-AC14850BD693Q36515308-7FFD4842-F38B-4762-A45B-A8C452555506Q36566007-02621C92-003D-4B9F-BC0C-ACC60D760FA3Q36597808-EB6F8570-7901-40A9-929A-52247C0C3D91Q37630100-9EAFEACA-7B93-4167-95C5-E7509A4367D5Q38091151-ADB1E9EE-27D4-4649-9C23-EAD2A009D1B2Q38367977-E995D47B-A930-4740-ABFD-3B909FD72599Q39259388-9C310F8F-ACB0-4792-A818-91D6402D1765Q41862916-41350877-8413-4900-9D83-DC4025A2378CQ41870434-C7B29362-F9AA-472F-BDE4-7347B224D8BCQ42428091-16B84ED7-4C85-4064-96F8-7055B2AAD99BQ42451952-53B212B7-093E-454A-80E7-7AFF232F5A8EQ43556329-6606AE1A-7A5D-4568-9EAF-3506048E4E0FQ47149052-A3DF65D7-5E55-438C-8551-5ED581FC336CQ51767077-2207CFD5-9F2B-4199-BB10-F33AD4DA4D0AQ53622309-89662F39-62FB-44C2-B415-FE87221EB42EQ55049004-1F712DEE-C68D-4F3C-8ABD-3CBB170A881A
P2860
Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@ast
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@en
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@nl
type
label
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@ast
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@en
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@nl
prefLabel
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@ast
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@en
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@nl
P2093
P2860
P356
P1476
Wnt1 neuroprotection translate ...... ochondrial apoptotic pathways.
@en
P2093
Jinling Hou
Kenneth Maiese
Yan Chen Shang
Zhao Zhong Chong
P2860
P304
P356
10.4161/OXIM.3.2.11758
P577
2010-03-01T00:00:00Z